| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.04 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |